Opus Capital Group, LLC Merck & Co., Inc. Transaction History

Opus Capital Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 04, 2018	SELL	$50.96 - $59.23 $200,374 - $232,892	-3,932 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$51.62 - $61.64 $239,516 - $286,009	-4,640 Reduced 54.13%	3,932 $222,000
Q3 2017 Nov 07, 2017	BUY	$58.67 - $63.13 $502,919 - $541,150	8,572	8,572 $549,000

3,826

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Opus Capital Group, LLC with notifications on news.